Cargando…
The biology of myelodysplastic syndromes: unity despite heterogeneity
Myelodysplastic syndromes (MDS) traditionally have been grouped together as a disease entity based on clinical phenomena seen in association. Despite the similarities, there is great heterogeneity among the syndromes. Recent insights have shown, however, that there exists a biologically cohesive the...
Autores principales: | Raza, Azra, Cruz, Raymond, Latif, Tahir, Mukherjee, Siddhartha, Galili, Naomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222260/ https://www.ncbi.nlm.nih.gov/pubmed/22184517 http://dx.doi.org/10.4081/hr.2010.e4 |
Ejemplares similares
-
Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome
por: Galili, Naomi, et al.
Publicado: (2012) -
An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome
por: Ebert, Benjamin L, et al.
Publicado: (2008) -
Oral Ezatiostat HCl (TLK199) and Myelodysplastic syndrome: A case report of sustained hematologic response following an abbreviated exposure
por: Quddus, Fahd, et al.
Publicado: (2010) -
Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML)
por: Galili, Naomi, et al.
Publicado: (2008) -
DNMT3a mutations in high-risk myelodysplastic syndrome parallel those found in acute myeloid leukemia
por: Ewalt, M, et al.
Publicado: (2011)